Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
When using nutritional supplements, please consult with your physician if you are undergoing treatment for a medical condition or if you are pregnant or lactating
Keep yourself hydrated by drinking small sips of water
Size View COA 20mg View COA 30mg View COA 40mg Research reference Overview Retatrutide (LY-3437943) is an investigational triple-receptor agonist that combines activity at the GLP-1, GIP and glucagon receptors in a single 39-residue peptide backbone
The safety considerations around peptide medications are serious, and unregulated products carry real risks including contamination, incorrect dosing, and lack of sterility
Ein weiteres Prparat, CagriSema (GLP-1 + Amylin) , befindet sich aktuell in der klinischen Phase-3-Prfung
